Pharmacogenetics and Genomics
| Pharmacogenetics and Genomics
|
|
|---|---|
| description | Peer-reviewed journal |
| Area of Expertise | Pharmacology and genetics |
| language | English |
| publishing company | Wolters Kluwer Health ( Netherlands ) |
| First edition | 1991 |
| Frequency of publication | 12 / year |
| editor | Matthias Schwab and Mark J. Ratain |
| Web link | Website of the journal |
| ISSN (print) | 1744-6872 |
Pharmacogenetics and Genomics , or Pharmacogenet for short . Genome. , is a scientific journal published by Wolters Kluwer Health-Verlag. The first issue appeared in October 1991. At that time, the journal was still published under the name Pharmacogenetics ; the name was only extended in 2005. Currently twelve issues are published a year. The journal publishes articles from the fields of pharmacogenomic basic research and clinical application, whereby epidemiologically and toxicologically oriented articles are also taken into account.
The impact factor in 2014 was 3.481. According to the statistics of the ISI Web of Knowledge , this impact factor ranks the journal 60th out of 254 journals in the pharmacology and pharmacy category , 52nd out of 167 journals in the genetics and inheritance category and in the biotechnology and applied microbiology category ranked 36th out of 162 journals.
The editor-in-chief is Matthias Schwab, Dr. Margarate Fischer-Bosch Institute for Clinical Pharmacology , Stuttgart and Mark J. Ratain , University of Chicago , United States of America.
Web links
Individual evidence
- ↑ a b website of the journal ; Retrieved February 8, 2013.
- ↑ 2014 Journal Citation Reports Science Edition (Thomson Reuters, 2015).
- ^ Website of Matthias Schwab in Stuttgart , accessed on February 8, 2013
- ↑ site of Mark Ratain in Chicago , accessed on February 8, 2013